000			01980 a2200637 4500
005			20250514020309.0
264		0	_c20011219
008			200112s 0 0 eng d
022			_a0140-6736
024	7		_a10.1016/s0140-6736(01)06844-1 _2doi
040			_aNLM _beng _cNLM
100	1		_avan der Lely, A J
245	0	0	_aLong-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. _h[electronic resource]
260			_bLancet (London, England) _cNov 2001
300			_a1754-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcromegaly _xdrug therapy
650	0	4	_aAdult
650	0	4	_aBlood Glucose _xdrug effects
650	0	4	_aCohort Studies
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aGrowth Hormone _xblood
650	0	4	_aHuman Growth Hormone _xanalogs & derivatives
650	0	4	_aHumans
650	0	4	_aInsulin _xblood
650	0	4	_aInsulin-Like Growth Factor I _xmetabolism
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aReceptors, Somatotropin _xantagonists & inhibitors
700	1		_aHutson, R K
700	1		_aTrainer, P J
700	1		_aBesser, G M
700	1		_aBarkan, A L
700	1		_aKatznelson, L
700	1		_aKlibanski, A
700	1		_aHerman-Bonert, V
700	1		_aMelmed, S
700	1		_aVance, M L
700	1		_aFreda, P U
700	1		_aStewart, P M
700	1		_aFriend, K E
700	1		_aClemmons, D R
700	1		_aJohannsson, G
700	1		_aStavrou, S
700	1		_aCook, D M
700	1		_aPhillips, L S
700	1		_aStrasburger, C J
700	1		_aHackett, S
700	1		_aZib, K A
700	1		_aDavis, R J
700	1		_aScarlett, J A
700	1		_aThorner, M O
773	0		_tLancet (London, England) _gvol. 358 _gno. 9295 _gp. 1754-9
856	4	0	_uhttps://doi.org/10.1016/s0140-6736(01)06844-1 _zAvailable from publisher's website
999			_c11647844 _d11647844